Chaoneng He
Hangzhou, 310022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
NAT10 drives chemoresistance in AML through ac4C-dependent stabilization of PLEKHA4.
Journal: Biochemical pharmacology
Published: May 18, 2026
Cost-effectiveness analysis of rezvilutamide versus bicalutamide in the treatment of metastatic hormone-sensitive prostate cancer.
Journal: BMJ open
Published: July 13, 2024
Hematological toxicity of cyclin-dependent kinase 4/6 inhibitors in patients with breast cancer: a network meta-analysis and pharmacovigilance study.
Journal: Expert opinion on drug safety
Published: May 16, 2024
Evaluation of omadacycline regimens for community-acquired bacterial pneumonia patients infected with Staphylococcus Aureus by pharmacokinetic/pharmacodynamic analysis.
Journal: Journal of chemotherapy (Florence, Italy)
Published: April 23, 2024
Cost-effectiveness analysis of tislelizumab plus chemotherapy as the first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma in China.
Journal: PloS one
Published: June 07, 2023
Population pharmacokinetics and toxicity correlation analysis of free and liposome-encapsulated doxorubicin in Chinese patients with advanced breast cancer.
Journal: Cancer chemotherapy and pharmacology
Published: April 04, 2023
Reply to "A better interpretation of data regarding the opioid switching to methadone".
Journal: BMC palliative care
Published: February 16, 2023
A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma.
Journal: Journal of oncology
Published: July 19, 2022
Cost-effectiveness of PARP inhibitors in malignancies: A systematic review.
Journal: PloS one
Published: June 14, 2022
Methadone switching for refractory cancer pain.
Journal: BMC palliative care
Published: February 12, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026